348150 — KoBioLabs Cashflow Statement
0.000.00%
Last trade - 00:00
- KR₩144bn
- KR₩120bn
- KR₩33bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -44,067 | -55,072 | -15,382 | -23,030 | -14,683 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 38,097 | 45,355 | 656 | 4,609 | -3,063 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 117 | -3,263 | 2,013 | 958 | 2,398 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -5,709 | -12,771 | -12,481 | -16,556 | -13,832 |
Capital Expenditures | -290 | -276 | -5,551 | -14,765 | -15,562 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -27,142 | 21,267 | -25,603 | -47,049 | 23,754 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -27,432 | 20,992 | -31,154 | -61,814 | 8,192 |
Financing Cash Flow Items | — | — | — | — | -9.89 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 30,605 | 31,045 | 55,741 | 36,310 | 4,046 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -2,537 | 39,348 | 12,066 | -42,260 | -386 |